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Initiation of Platelet Adhesion
by Arrest onto Fibrinogen
or Translocation on von Willebrand Factor
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and Thrombosis Iba as well as aIIbb3 (Ruggeri et al., 1983; Ikeda et al.,
1991; Alevriadou et al., 1993), with a distinctive role inDivision of Experimental Hemostasis and Thrombosis
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high shear stress (Bellinger et al., 1987; Nichols et al.,and Department of Vascular Biology
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We now demonstrate that the mechanisms initiatingLa Jolla, California 92037
platelet deposition onto immobilized fibrinogen and vWF
under flow are fundamentally distinct. Fibrinogen sup-
ports attachment that is immediately irreversible butSummary
progressively less efficient with increasing shear stress.
In contrast, vWF initially supports a slow and continuousWe have identified two distinct mechanisms initiating
motion on the surface that is particularly efficient inthe adhesion of flowing platelets to thrombogenic sur-
capturing platelets under very high shear stress condi-faces. The integrin aIIbb3 promotes immediate arrest
tions and eventually leads to irreversible attachment.onto fibrinogen but is fully efficient only at wall shear
These different properties may explain the necessaryrates below 600±900 s21, perhaps because of a rela-
participation of both substrates in normal hemostasistively slow rate of bond formation or low resistance
and may illustrate the adaptation of cellular adhesionto tensile stress. In contrast, glycoprotein Iba binding
mechanisms to the effects of varying hemodynamicto immobilized von Willebrand factor (vWF) appears
forces in the circulation.to have fast association and dissociation rates as well
as high resistance to tensile stress, supporting slow
movement of platelets in continuous contact with the Results and Discussion
surface even at shear rates in excess of 6000 s21. This
eventually allows activated aIIbb3 to arrest platelets Distinct Shear Rate Dependence of Platelet
onto vWF under conditions not permissive of direct Interaction with Immobilized Fibrinogen,
binding to fibrinogen. The coupling of these different Fibrin, and vWF
functions may be crucial for thrombogenesis. Initial experiments were aimed at obtaining a quantita-
tive evaluation of surface coverage by platelets at
selected timepoints, each corresponding to a singleIntroduction
frame of videotape recordings with a time resolution of
0.033 s. The corresponding results, therefore, do notThe flow of blood imposes hydrodynamic stresses on
contain any information regarding the stability of adhe-vascular cells, including shear stress (Whitmore, 1968).
sion. Platelets in flowing whole blood containing aUnder these conditions, the establishment of contact
thrombin inhibitor as anticoagulant attached to immobi-between circulating elements and the vessel wall re-
lized fibrinogen and fibrin at low but not high wall shearquires sufficient adhesive strength to oppose fluid dy-
rates, regardless of whether full activation was pre-namic forces that would lead to detachment. Platelets
vented or not by treatment with prostaglandin E1 (PGE1)provide a relevant paradigm of this biological process
(Figure 1). In contrast, thenumber of platelets interactingsince their adhesive functions are necessary to limit
with vWF was greater at high shear rates and thrombiblood loss at sites of vascular injury (Weiss, 1975; Sixma
developed when activation was not inhibited by PGE1and Waster, 1977), including areas of the circulation with
(Figure 1). In all subsequent experiments, fibrinogenthe highest levels of shear stress (Tangelder et al., 1988).
and fibrin gave essentially the same results, and onlyMoreover, platelets play a key role in the acute occlusion
data obtained with the former are reported here.of atherosclerotic arteries (Fuster et al., 1992a, 1992b),
another event that may involve adhesion under high The time course of single platelet adhesion, mea-
sured in the presence of PGE1 to inhibit thrombus forma-shear stress (Back et al., 1977; Gibson et al., 1993).
During both normal hemostasis or pathological throm- tion, demonstrated progressive accumulation onto fi-
brinogen as opposed to the rapid attainment of a plateaubosis, stable platelet attachment at the site of lesion is
necessary to support thrombus formation. in the number of platelets interacting with vWF (Figure
2). In the latter case, adhesion never increased aboveAmong the substrates that mediate platelet adhesion,
fibrinogen and von Willebrand factor (vWF) are clearly the level reached after approximately 1 min, even when
surface coverage was partial at the lower shear ratesof pathophysiological relevance because of bleeding
disorders known to be associated with their respective tested (Figure 2). Quantitative evaluation of the number
of platelets interacting with the surface after perfusionisolated deficiencies (Ruggeri, 1993; Weiss and Rogers,
1971; Tschopp et al., 1974). Fibrinogen can support both for 5 min showed maximal platelet deposition onto fi-
brinogen at 50 s21, with progressive decrease as flowplatelet±surface and platelet±platelet interactions, ad-
hesion and aggregation, respectively (Coller, 1980; Mus- increased and essentially no adhesion at 1500 s21 (Figure
2). Conversely, adhesion to vWF was minimal at 50 s21tard et al., 1978), by binding to the glycoprotein (GP)
IIb±IIIa receptor (integrin aIIbb3) (Nachman and Leung, and maximal at 1500 s21 (Figure 2). For reference, the
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Figure 2. Effect of Wall Shear Rate on Platelet Interaction with Im-
mobilized Fibrinogen and vWF
Blood containing PGE1 to inhibit platelet activation was perfused
through the parallel plate flow chamber as described in the legend
to Figure 1. (Top) Number of platelets attached to the surface as a
function of perfusion time at three different wall shear rates. Note
the progressive accumulation of platelets onto fibrinogen (left) as
opposed to the attainment of maximal coverage on vWF after ap-
proximately 1 min (right). Note also that the extent of coverage is
inversely related to the shear rate on fibrinogen but directly related
to it on vWF. (Bottom) Number of single platelets attached to immo-
bilized fibrinogen (left) or vWF (right) in an area of 35,567 mm2 after
perfusion for 5 min as a function of wall shear rate. The results
represent the mean and standard error of six experiments with blood
from different donors.
the monoclonal antibody LJ-CP8 (Niiya et al., 1987) abol-
ished interaction with immobilized fibrinogen but not
with vWF (Figure 3). The latter process was markedly
Figure 1. Real-Time Observation of Platelet Interaction with Sur- inhibited by blocking the GP Iba receptor with a soluble
face-Bound Fibrinogen, Fibrin, and vWF recombinant fragment corresponding to the A1 domain
Substrates coated onto glass coverslips were placed in a parallel of vWF (Sugimoto et al., 1993), a treatment that had no
plate flow chamber that produces a linear variable wall shear rate.
effect on platelet interaction with fibrinogen (Figure 3).Blood containing PPACK as anticoagulant and treated with the fluo-
The monoclonal antibodies LJ-Ib1, against GP Ibarescent dye mepacrine for platelet visualization was perfused
(Handa et al., 1986), and NMC-4, against the A1 domainthrough the chamber at 378C. Each single-frame image shown here,
corresponding to an area of 8892 mm2, was obtained after perfusion of vWF (Fujimura et al., 1991), had the same effects as
for 5 min at two different wall shear rates, as indicated. The six top the recombinant vWF fragment; EDTA and the Arg-Gly-
panels show blood containing no PGE1. The six bottom panels show Asp-containing snake venom protein applaggin, both
blood treated with PGE1 to inhibit platelet activation. Note that sur- inhibitors of ligand binding to aIIbb3 (Ginsberg et al., 1986;face-bound fibrinogen (left) and fibrin (middle), unlike vWF (right), fail
Savage et al., 1990), had the same effects as the anti-to support platelet attachment at 1500 s21; note also the presence of
body LJ-CP8. These results prove, in agreement withplatelet aggregates (thrombi) on the vWF surface, but only at the
higher shear rate and when platelet activation is not inhibited. These current knowledge (Savage et al., 1992), that aIIbb3 is the
images are representative of the results obtained in six experiments essential receptor supporting adhesion to fibrinogen or
with blood from different donors. fibrin, whereas GP Iba is absolutely required for the
initial interaction with vWF.
maximum wall shear rate in the normal human circula-
tion has been estimated to occur in small arterioles of Dynamic Aspects of Platelet Adhesion to Fibrinogen
Real-time analysis at a sampling frequency of 30 frames10±50 mm diameter and to vary between approximately
500 and 5000 s21 with a median value of 1700 s21 per second demonstrated that the interaction of plate-
lets in flowing blood with immobilized fibrinogen was(Tangelder et al., 1988). The lack of platelet interaction
with immobilized fibrinogen under high shear stress was instantaneously irreversible in greater than 90% of the
observed adhesion events, regardless of whether fullnot due to detachment of the ligand or any other irrevers-
ible changes on the surface, since decreasing the shear activation was inhibited with PGE1 or not (Figure 4).
Thus, arrest onto the surface was not preceded by anyrate to 50 s21 after 5 min of perfusion at 1500 s21 resulted
in the predicted level of adhesion shown in Figure 2. appreciable deceleration below the hydrodynamic ve-
locity expected for an unencumbered particle in the flowFunctional inhibition of the platelet aIIbb3 receptor with
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field under examination. This could be verified experi-
mentally when flow corresponded to wall shear rates
below 200 s21, since platelets close to the surface could
be visualized and tracked; at higher flow rates, platelets
were not visible before arresting. After the initial attach-
ment was established, in less than 10% of the cases
was the centroid of each individual platelet displaced
by more than the corresponding diameter from the site
where it first appeared in the recording, regardless of
the point in time at which adhesion occurred (Figure 4).
A comparable bimodal distribution of events, with im-
mediate transition from no interaction to stable adhe-
sion, has been observed for nucleated cells attaching
to surfaces through antigen±antibody and immunoglob-
ulin E (IgE)±Fce interactions (Tempelman and Hammer,
1994). Theoretical and experimental considerations
have suggested that association rate constants varying
between 105 and 107 M21 s21 may determine whether a
given bond can mediate irreversible attachment at shear
rates between 30 and 100 s21 (Tempelman and Hammer,
1994). The binding of purified aIIbb3 to immobilized fibrin-
ogen has been reported to have an association rate
constant of 3.3 6 1 3 104 M21 s21 (Huber et al., 1995),
but it is not known whether the same estimate applies
to the membrane-bound receptor. In fact, the interaction
has been shown here to be effective in supporting imme-
diate arrest of flowing platelets at a limit shear rate
between 1000 and 1500 s21, greater than predicted from
Figure 3. Effect of Inhibiting aIIbb3 and GP Iba Receptor Function the experiments with nucleated cells attaching through
on Platelet Interaction with Immobilized Fibrinogen and vWF at Dif-
bonds possibly characterized by faster forward rateferent Wall Shear Rates
(Tempelman and Hammer, 1994). Other factors, there-Blood containing PGE1 to inhibit platelet activation was perfused
fore, may influence platelet adhesion to fibrinogen. Forover immobilized fibrinogen (left) or vWF (right) under conditions
example, high receptor density per unit area on plateletsdescribed in the legend to Figure 1, and the number of single plate-
lets attached to the surface after 5 min was measured in an area should increase the probability of bond formation. Fur-
of 35,567 mm2. (Top) Control samples. (Middle) Platelet aIIbb3 function thermore, the drag force imposed by flow on adherent
was inhibited with 100 mg/ml monoclonal antibody LJ-CP8 F(ab9)2. platelets is less, because of their smaller size, than on
(Bottom) GP Iba function was inhibited with 5 mM rvWF(445±733), a
larger nucleated cells, reducing the tensile stress onrecombinant vWF A1 domain fragment containing the GP Ib±binding
bonds and minimizing its effects on the dissociation ratedomain.
(Bell, 1978). On the other hand, biomechanical proper-
ties of the aIIbb3±fibrinogen interaction may explain why
adhesion to fibrinogen cannot occur above a limit shear
rate, but remain to be elucidated. Bonds may form at
high shear rates, but their initial resistance to tensile
stress may be insufficient to oppose shear forces and
maintain platelets attached to the surface. Breaking at
the weakest point may occur at the ligand±receptor in-
terface or, for example, as a consequence of receptor
extraction from themembrane (Alon et al., 1995). Indeed,
the arrest of flowing platelets may depend on events
occurring rapidly after receptor occupancy, including
generation of intracellular signals and cytoskeletal re-
arrangement with spreading (Savage et al., 1995), possi-
Figure 4. Stability of Platelet Attachment to Immobilized Fibrinogen
bly influencing the dissociation rate of the aIIbb3±and vWF
fibrinogen interaction, its anchorage to the membrane,Blood was perfused through the parallel plate flow chamber under
or both. Of note, we found that more than 80% of theconditions described in the legend to Figure 1. After perfusion for
platelets that attached at permissive shear rates re-5 min at a wall shear rate of 50 s21, consecutive images were cap-
tured from videotapes and analyzed for platelet movement (for defi- mained in a stable position when flow was raised to a
nition see Experimental Procedures). Results represent the percent- level (1500 s21) not compatible with initial adhesion.
age of platelets displaced from their initial position as a function of
time relative to the total number of platelets attached to the surface Dynamic Aspects of Platelet Adhesionin the first image analyzed. Note that after 40 s, all (100%) platelets
to vWFhave moved on vWF but less than 10% have moved on fibrinogen,
In remarkable contrast with the findings obtained withregardless of whether platelet activation is inhibited (left) or not
(right). immobilized fibrinogen, virtually 100% of all platelets
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decreased (Figure 6). Prolonged observation demon-
strated that some platelets had become irreversibly
attached and were the site of thrombus formation (see
Figure 1). In contrast, after inhibition of activation with
PGE1 or blocking aIIbb3 binding function, 100% of plate-
lets interacting with the surface showed the same veloc-
ity of translocation after 5 min of flow at 1500 s21 as
that seen with untreated platelets after 1 min (Figure 6).
These results demonstrate that the adhesion of flow-
ing platelets to immobilized vWF is a two-step dynamic
process. The first, mediated by GP Iba, consists of low
Figure 5. Time-Lapse Analysis of Platelet Movement on Surface velocity surface translocation that continues until plate-
Bound vWF and Fibrinogen
lets become activated; at that point, aIIbb3, not required
The platelet count in blood containing PGE1 was reduced to 5000 nor sufficient to mediate the initial attachment, can sup-per microliter, without affecting other blood cells, by removing plate-
port irreversible arrest of individual platelets and subse-let-rich plasma after differential centrifugation and replacing it with
quent thrombusformation. This second interaction mostautologous platelet free plasma. This enabled monitoring the move-
ment of individual platelets when blood was perfused at a wall likely depends onthe integrin recognition sequence Arg-
shear rate of 1500 s21 over the vWF-coated surface, which would Gly-Asp in the carboxy-terminal domain of vWF,
otherwise be saturated with platelets (compare the right panel here previously shown to mediate shear-induced platelet ag-
with the lower right panel of Figure 1). In the experiments performed gregation (Ikeda et al., 1991) as well as adhesion and
with vWF, platelets were treated with 100 mg/ml monoclonal anti-
thrombus formation on exposed subendothelium (Weissbody LJ-CP8 F(ab9)2 to block aIIbb3 receptor function. Platelet-de-
et al., 1993). Under the experimental conditions tested,pleted blood was perfused over surface-bound fibrinogen or vWF
at the wall shear rates indicated. Images were captured from the using blood containing a thrombin inhibitor as anticoag-
videotape over a 5 s interval at a sampling rate of 30 per second ulant, demonstrable consequences of activation, e.g.,
and superimposed. Note the translocation on vWF (two right panels) platelet aggregation, were seen only at high shear rates,
compared with stable attachment to fibrinogen (left panel). consistent with the concept that, in the absence of other
agonists, shear stress must be above a threshold limit
to cause platelet activation dependent on the vWF±GP
establishing contact with surface bound vWF exhibited Ib interaction (Ikeda et al., 1991, 1993). Decreasing ve-
initially transient attachment even at the lowest levels locity of translocation and eventual irreversible attach-
of shear stress tested (Figure 4). Thus, the interaction ment were seen only after several minutes of perfusion
of platelets in flowing blood with immobilized vWF re- and may depend on progressive changes in the surface
sulted in continuous movement (Figure 5). The charac- microenvironment related to the release of agonists from
teristics of this spatial displacement varied depending platelets interacting with the surface. It is known, for
on the shear rate, the time at which measurements were example, that ADP is needed to support the aggregation
made relative to the initial contact and depending on of platelets exposed to shear stress in suspension
whether full platelet activation, aIIbb3 function, or both (Moake et al., 1988). The attainment of sufficient local
were inhibited ornot. However, because of thesmall size concentrations of agonists may be favored by the high
and uniform fluorescence of the anucleated platelets, it platelet capture efficiency of immobilized vWF and the
was not possible to define whether this motion included low velocity, i.e., long transit time, of platelets on the
a rotational component (rolling) or not (translation). At surface.
shear rates below 340 s21, the movement was more
clearly of the ªstop±startº type, with transient arrests of
up to several seconds in duration separated by surface Characteristics of Platelet Motion on vWF
translocation at lower than predicted hydrodynamic ve- The first step of the process of platelet adhesion to
locity. This pattern of movement tended to persist un- vWF, mediated by interaction with GP Iba, was further
changed in time whether or not platelets had been evaluated after blocking activation with PGE1 to prevent
treated with PGE1 or aIIbb3 binding function had been changes due to the secondary engagement of aIIbb3 (Fig-
blocked directly. At 50 s21, the time needed for all plate- ure 6). The maximum recorded velocity of translocation
lets interacting with immobilized vWF to move by a dis- was 19 mm/s at a wall shear rate of 6000 s21, but most
tance of at least one diameter was greater than 30 s platelets moved less than 10 mm/s at any shear rate
(see Figure 4). The characteristics of motion under tested (Figure 7). In comparative terms, the velocity of
higher shear stress exhibited a pattern that varied with platelets moving on immobilized vWF was approxi-
time. After 1 min of flow at a shear rate of 1500 s21, mately an order of magnitude lower than that reported
100% of untreated platelets interacting with the surface for leukocytes rolling on selectins at equivalent shear
were displaced from their initial position by a distance rate levels (Lawrence and Springer, 1991) and at least
greater than their own diameter within 6 s (Figure 6). two orders of magnitude lower than that of platelets
The movement was still of the stop±start type, although reported to be occasionally rolling on stimulated endo-
less clearly so when observed in real time. After 5 min thelium (Frenette et al., 1995). The velocity of platelets
of flow, however, approximately 10% of the platelets in interacting with the surface increased nonlinearly as a
a view field were firmly attached to the surface;displace- function of increasing flow, with a tendency to reach a
ment of the remaining 90% occurred more slowly than steady level at shear rates above 1500 s21 (Figure 7).
The velocity of translocation relative to that calculatedat the earlier perfusion time, and thus their velocity was
Platelet Adhesion to Fibrinogen and vWF
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Figure 6. Effects of Platelet Activation and
aIIbb3 Function on the Stability of Platelet In-
teraction with Immobilized vWF
Blood was perfused through the parallel plate
flow chamber under conditions described in
the legend to Figure 1, and movement was
analyzed as described in the legend to Figure
4 at a wall shear rate of 1500 s21. (Left) Move-
ment of untreated platelets (no PGE1) after
perfusion for 1 or 5 min. (Middle) Movement
of PGE1-treated platelets after perfusion for
5 min. (Right) Movement of platelets treated
with 100 mg/ml anti-aIIbb3 antibody LJ-CP8
F(ab9)2 after perfusion for 5 min.
for a theoretical unencumbered spherical particle was It is apparent that the first step in the mechanism
described here must rely on a fast rate of bond formation2% at 50 s21 but less than 0.1% at 6000 s21, assuming
a rigid sphere with the radius of an average platelet between GP Iba and the vWF A1 domain, allowing an
initial contact to be established even when plateletsmoving freely in close proximity (300 nm) to the surface
(Goldman et al., 1967). Of note, platelets moved slowly are moving at high hydrodynamic velocity. Indeed, the
ability of immobilized vWF to recruit platelets onto aon vWF at shear rates that exceed the values in the
normal circulation and are likely to be encountered only surface may be limited only by physical separation pre-
venting the interaction from occurring, as suggestedin stenosed arteries (Gibson et al., 1993; Strony et al.,
1990; Back et al., 1977), signifying the ability of immobi- by the observation that steady-state surface coverage
increases progressively with increasing flow rates be-lized vWF to localize platelets onto a surface even under
biologically extreme conditions. fore reaching a stable level essentially corresponding
to complete surface coverage (see Figure 2). This high
capturing efficiency is likely to depend on the fact that
multiple bonds can be formed rapidly and with high local
density, owing to multivalence of the polymeric ligand
(Ruggeri, 1993) and high membrane density of GP Iba
receptor molecules (Ruggeri et al., 1983). Such features
may become crucial when the strain on the bonds in-
creases, explaining why inhibitors of the vWF±GP Iba
interaction are relatively less efficient at lower than
higher shear (see Figure 3). With less mechanical stress,
in fact, even a small number of remaining functional
receptors may promote measurable adhesion events.
Once formed, it is reasonable to assume that the bonds
oppose high resistance to tensile stress since interac-
tions are observed even at shear rate values greater
than 6000 s21, corresponding to a drag force on the
average platelet (1.2 mm radius) of 1108 pN, calculated
according to Goldman et al. (1967). The fact that bonds
break even at the lowest shear rate levels tested (50 s21,
corresponding to a drag force on the average platelet of
9.2 pN) presumably reflects an inherently fast dissocia-
tion rate independent of stress. Estimates of this param-
eter are not yet available for GP Iba binding to the vWF
A1 domain in the absence of exogenous modulators. A
bonding mechanism with fast association and dissocia-
tion rates, with the possibility of extending before failing
under stress, is thought to represent a key requirement
Figure 7. Frequency Distribution of the Velocity of Platelet Move-
for the rolling adhesion of leukocytes (ToÈzeren and Ley,ment on vWF as a Function of Wall Shear Rate
1992); it is now apparent that a similar mechanism canPlatelet depleted blood containing PGE1, prepared as described in
be provided by the interaction of GP Iba and the vWF A1the legend to Figure 5, was perfused over immobilized vWF in the
domain and is essential for platelet function at extremeparallel plate flow chamber as described in the legend to Figure 1.
After platelet surface coverage had reached equilibrium (between conditions of high flow.
1 and 2 min; see Figure 2), consecutive images were captured from
the videotape, and the average velocity of individual platelets was Functional Integration of Receptors and Adhesive
calculated by measuring the distance traversed over a 5 s interval. Interactions Supporting Platelet AdhesionThe distribution of velocities at each indicated wall shear rate was
under Shear Stressobtained by measuring 120±200 platelets using data from four sepa-
Our studies point to a novel interpretation of the processrate experiments; results shown are representative of all platelets
present on the surface. initiating platelet thrombus formation at sites of vascular
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injury. Two adhesion receptors, aIIbb3 and GP Iba, and platelet thrombus formation in response to vascular in-
jury, like leukocyte extravasation in response to inflam-two distinct substrates, fibrinogen and vWF, are re-
quired to provide the biomechanical properties neces- matory stimuli, may be initiated by transient surface
interactions preceding stable adhesion. In the case ofsary to mediate stable platelet adhesion under all condi-
tions of shear stress encountered in the circulation. The platelets, two domains in the same ligand, vWF, mediate
the initial contact and the subsequent irreversible adhe-integrin aIIbb3 supports immediate surface arrest of flow-
ing platelets but can interact only with immobilized fi- sion by interacting with two different receptors. Unique
requirements of the hemostatic process, mainly thebrinogen or fibrin before activation (Savage et al., 1992)
and, presumably because of a relatively slow rate of need to take place in small arterioles with the highest
levels of shear stress in the circulation, may explain thebond formation, a low initial resistance to tensile stress,
or both, works efficiently only at the lower levels of evolution of the vWF-dependent adhesion mechanism
to integrate the efficient and direct interaction of nonac-shear stress. In contrast, the interaction of GP Iba with
immobilized vWF is inherently not sufficient to arrest tivated aIIbb3 with fibrinogen or fibrin at lower shear. Our
findings provide novel approaches to understanding theplatelets but results in a very marked decrease in veloc-
ity, relative to hydrodynamic flow, when surface contact distinct role of seemingly redundant adhesion systems
in the process of hemostasis, highlighting the possibilityis established. Moreover, possibly because of a fast rate
of bond formation and high resistance to tensile stress, of selective pharmacologic modulation to control the
onset and progression of pathologic arterial thrombosis.this function is efficiently displayed at all levels of shear
stress relevant for normal and pathological thrombus
formation. Two important events take place after the Experimental Procedures
slow surface translocation on vWF begins: aIIbb3 be-
comes activated and, because of the low velocity of Blood Donors
Blood was collected from the antecubital vein of healthy adult do-platelets, sufficient time is available for bond formation
nors through a 19-gauge needle into syringes containing as antico-with vWF; the latter interaction, like in the case of aIIbb3
agulant the thrombin inhibitor D-phenylalanyl-L-prolyl-L-argininebinding to immobilized fibrinogen, leads to platelet ar-
chloromethyl ketone dihydrochloride (PPACK) (40 mM final concen-
rest onto the surface. Thus, aIIbb3 is essential for the tration) and supplemented, where indicated, with PGE1 (10 mM final
stability of adhesion, but GP Iba is first required to re- concentration). None of the donors had taken aspirin (or other drugs
duce the velocity of platelets contacting the surface known to affect platelet function) in the preceding 10 days.
under high flow conditions, thereby prolonging the time
available for the occurrence of other interactions. The Purification of Adhesive Proteins
Fibrinogen was purified from blood collected in acid±citrate±two receptors, therefore, have complementary roles.
dextrose anticoagulant containing 0.1 M (final concentration)The corresponding adhesive substrates, fibrinogen
e-aminocaproic acid, using the glycine precipitation method (Kazaland vWF, are also complementary in initiating platelet
et al., 1963) as previously reported (Niiya et al., 1987). High molecular
deposition on thrombogenic surfaces, the former sup- weight contaminants were removed by gel permeation chromatog-
porting rapid and efficient platelet adhesion at lower raphy through a Sepharose CL-4B column. Analysis of the purified
shear stress and the latter allowing platelets to interact fibrinogen by 7.5% polyacrylamide gel electrophoresis in the pres-
ence of SDS and under reducing conditions showed the characteris-with the surface regardless of shear stress. However,
tic Aa, Bb, and g chains (McKee et al., 1966). vWF was purified andwhen shear stress is low, the function of vWF is initially
characterized using methods previously described in detail (Ruggerilimited because of the lack of recognition by the recep-
et al., 1983). Absence of fibronectin and fibrinogen contamination
tor, aIIbb3, that can mediate irreversible adhesion; only was verified by immunoblotting with monospecific antibodies.
after platelet activation takes place can platelets arrest
onto immobilized vWF. In the setting of a vascular lesion, Preparation of Fibrin-, Fibrinogen-,
subendothelial components (like collagen) or soluble and vWF-Coated Coverslips
Fibrinogen and vWF solutions were prepared in 0.04 M phosphateplatelet agonists (like ADP and epinephrine) may en-
buffer (pH 7.4) containing 0.15 M NaCl (PBS) at a final concentrationhance the efficiency of the hemostatic response by con-
of 100 mg/ml and immediately applied to a horizontal glass coversliptributing synergistically to aIIbb3 activation. Such a mech-
(24 mm 3 50 mm; 200 ml per coverslip) and spread evenly over allanism could critically accelerate the attainment of
but the first 10 mm, which remained uncoated to facilitate handling.
irreversible platelet adhesion at sites of injury where Coated coverslips were then placed in a humid environment at room
plasma vWF becomes immobilized by binding to colla- temperature (228C±258C) for 90 min before being rinsed with PBS
gen in the vessel wall, particularly under high shear and assembled in the flow chamber. Preliminary studies showed
that the protein concentration of the coating solution was in excessstress conditions, and explain the functional relevance
of that required to saturate the glass surface and support optimumof the a2b1 collagen receptor in hemostasis (Nieuwen-
platelet adhesion. However, coating solutions with lower proteinhuis et al., 1985).
concentrations were not used because they did not readily spread
In conclusion, we have shown that the bond between on the hydrophobic glass surface, and therefore larger volumes
vWF A1 domain and GP Iba complements aIIbb3 integrin were required for coating. Blocking thecoverslips with bovine serum
function in initiating platelet surface deposition under albumin (0.1 mg/ml) did not affect platelet adhesion, and uncoated
glass coverslips did not support platelet adhesion. Fibrin-coatedpathophysiologically relevant conditions of shear stress.
coverslips were prepared in the following manner: purified fibrino-The distinctive biomechanical feature provided by this
gen (2.0 mg/ml) in PBS was supplemented with Ca21 to a final con-interaction is represented by an initial surface transloca-
centration of 2.5 mM, and human a-thrombin was added to a final
tion at low velocity, crucial to enable subsequent irre- concentration of 0.3 NIH U/ml.A 100ml aliquot was then immediately
versible attachment as the selectin-mediated rolling of spread over a horizontal glass coverslip and maintained in a humid
leukocytes is needed for integrin-dependent arrest onto environment for 2 hr at room temperature before being assembled
in the flow chamber.the endothelium (Lawrence and Springer, 1991). Thus,
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Inhibitors of Platelet Adhesive Interactions frame number. Image analysis was performed using the Metamorph
software package (Universal Imaging Corporation). The first twoAll the murine monoclonal antibodies used in these experiments
were obtained and characterized as described previously. They consecutive frames in the series were then superimposed (by using
the logical AND function) so that the resultant image representedwere purified using protein A (Sigma) chromatography according to
published procedures (Ey et al., 1978). LJ-Ib1 (IgG1) reacts with the only the overlapping areas of the platelet at two different times.
The new image was then superimposed to the next frame, and theamino-terminal 45 kDa domain of GP Iba containing the vWF-bind-
ing site (Handa et al., 1986; Vicente et al., 1988, 1990) and inhibits process was continued until the overlapping area was equal to 0.
When this occurred, a platelet had moved by a distance greatercompletely vWF±GP Ib interaction under all experimental conditions
tested (Alevriadou et al., 1993). LJ-CP8 (IgG1) reacts with the GP than its diameter; if this did not occur, a platelet was considered
firmly attached during the period of observation. The time for individ-IIb±IIIa complex (aIIbb3) and blocks the activation-dependent binding
of soluble ligands to this receptor (Niiya et al., 1987; Weiss et al., ual platelet motion was computed, and the process was repeated
until all the platelets in the field of study moved or for a preselected1989) as well as platelet aggregation and thrombus formation under
all experimental conditions tested (Weiss et al., 1989). NMC-4 (IgG1) time interval, whichever occurred first.
reacts with the A1 domain of vWF that includes the disulfide bond
between residues Cys-509 and Cys-695 (Fujimura et al., 1991; Mohri Evaluation of Platelet Velocity
et al., 1989), and blocks the interaction between vWF and GP Ib The predicted velocity of platelets in flowing blood was defined as
under all the experimental conditions tested. Monovalent Fab frag- the velocity of a spherical particle, with the same diameter of a
ments of the antibodies were prepared by papain digestion and platelet, traveling in a shear field parallel to a smooth surface but
divalent F(ab9)2 fragments by pepsin digestion according to methods without interacting with it. In this calculation we assumed that the
previously described (Porter, 1959; Parham et al., 1982). After diges- average platelet radius was 1.2 mm, and we used the approximation
tion, Fc fragment was removed by passage through a protein A proposed by Goldman et al. (1967), which considers the effects of
column; purified Fab and F(ab9)2 were concentrated by Centriprep the proximity of the wall in the platelet path. Considering that the
(Amicon). A snake venom±derived disintegrin, applaggin, was used diameter of a coiled vWF molecule has been reported to be 0.3 mm
according to methods previously described (Savage et al., 1990). (Fowler et al., 1985), the distance of the center of the platelet to the
The recombinant fragment containing the GP Iba±binding domain wall was estimated to be 1.5 mm. Although blood is known to be a
of vWF (rvWF[445±733]) was expressed in Escherichia coli and puri- non-Newtonian fluid at shear ratesbelow 20 s21, it can beconsidered
fied to homogeneity as described previously (Sugimoto et al., 1991, Newtonian in the range of shear rates studied here (Fung, 1981). To
1993). calculate the velocity of platelets interacting with the surface, im-
ages were digitized from the recorded experiment at a sampling
rate of 30 frames per second using a computer-controlled SonyPerfusion Chamber and Epifluorescence Videomicroscopy
Platelet interaction with adhesive surfaces at various wall shear 9500 VCR and a Matrox Image LC frame grabber. The digitized
images had a size of 512 3 512 pixels (256 3 256 mm) and an opticalrates was studied using a modification of the Hele±Shaw flow cham-
ber described elsewhere (Usami et al., 1993). This flow chamber resolution of 0.5 mm. A total of 300 frames were digitized for each
experiment. Image processing was performed with the Metamorphhas a tapered silicone gasket that varies the shear rate at the wall
in a linear manner as a function of distance. Adhesive substrates software package. The position of the centroid of the platelets was
calculated for every frame, and their relative coordinates (x and y)coated onto glass coverslips formed the lower surface of the cham-
ber with a flow path height of 254 mm (determined by a silicone were measured. Centroid displacement was computed as a function
of time. Velocity was calculated as the distance traveled by therubber gasket). The flow chamber was assembled and filled with
PBS (pH 7.4). A syringe pump (Harvard Apparatus Incorporated) centroid divided by the time interval.
was used to aspirate blood through the flow chamber at a constant
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